HF Sinclair heads into the back half of September with its most interesting tension sitting on the Street rather than in the lending market: the stock has surged 21% in a month to $115.90, yet the analyst consensus has only just begun scrambling to close the gap between targets and price.
The analyst move this week was the standout. Raymond James lifted its target from $105 to $140 — well above the current price — while keeping its Strong Buy. Morgan Stanley moved in the same direction, raising to $127 from $78 and maintaining Overweight. Both actions landed on September 14, the day after the stock's strongest week in recent memory. Earlier in the month UBS pushed its Buy target to $126 from $105. The direction of travel is uniform: bulls are chasing a stock that has already moved. The constraint is the consensus, which still reads Hold, pulled down by neutral-to-cautious voices at Wells Fargo (Equal-Weight, $93), Barclays ($86), and Mizuho ($85). The mean price target of $102 now sits roughly 12% below the current price — a gap that will either close through fresh upgrades or through the stock giving ground toward the cluster of lower targets.
Short positioning has been stable since last week's note, but the context deserves an update. The September 10 jump that pushed short interest to 10 million shares — 5.5% of the free float — has not materially reversed. Short interest sits at 10.07 million shares, essentially flat on the week, while the stock has continued rallying. That means each short position is sitting on a larger mark-to-market loss. Availability remains extraordinarily loose at over 5,500% — roughly 113 million shares available against current short positions — so there is no mechanical squeeze pressure in the lending pool. Borrow cost has dropped sharply, now 0.29% versus 0.47% a week ago. The ORTEX short score has drifted marginally higher to 41.8, ranking in the 32nd percentile — positioned cautiously rather than alarmingly. The picture is of a deliberate bearish view that is simply losing ground to the tape.
One ownership detail worth flagging: activist filer REH Advisors holds a Schedule 13D position, last disclosed at 5.1% of the class — trimmed from 6.3% after the firm distributed 2.375 million shares on August 2 at around $89, a transaction worth over $212 million at that price. REH Advisors now appears in the institutional register at roughly 8.9 million shares and 5.0% of outstanding. As the standard caveat applies — 13D/G stakes are disclosed around the 5% threshold, and a holder who drops below 5% may not file again — the actual current position could be lower. What is clear is that a shareholder with activist standing has been actively reducing exposure into the rally.
The valuation setup is bifurcated. The stock trades at a PE of around 9x and EV/EBITDA of 5.75x — multiples that look inexpensive in absolute terms and have expanded modestly over the past 30 days as earnings estimates held firmer than the price suggested they would. EPS momentum ranks in the 89th percentile on a 90-day basis, meaning forward estimates have been rising consistently. The bull case leans heavily on free cash flow recovery in 2026 and margin expansion. The bear case centres on execution — lingering CEO leadership uncertainty and refining throughput that has disappointed in recent quarters. Factor scores place DINO at the 72nd percentile on EV/EBIT and 73rd on 30-day EPS momentum, but only the 22nd on forward EPS growth, a reminder that the recovery story is still more cyclical bounce than structural re-rating.
Among close peers, MPC gained 7.3% on the week and VLO rose 5.9% — both tracking DINO's move but trailing it slightly, suggesting the relative outperformance is holding. PBF was the outlier, declining 1.4% on the week, which separates the sector-wide tailwind from stock-specific momentum. The November 5 earnings date is the next hard catalyst, and the two most recent prints both saw the stock slip on the day — by 1.9% in August and 0.9% in late July — before recovering over the following week. The next note will therefore be as much about whether the analyst consensus finally capitulates upward as about whether the shorts who built their position at $92 decide the $115 level is the exit.
See the live data behind this article on ORTEX.
Open DINO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
